Structural and molecular basis for Cardiovirus 2A protein as a viral gene expression switch.
dc.contributor.author | Hill, Chris H | |
dc.contributor.author | Pekarek, Lukas | |
dc.contributor.author | Napthine, Sawsan | |
dc.contributor.author | Kibe, Anuja | |
dc.contributor.author | Firth, Andrew | |
dc.contributor.author | Graham, Stephen | |
dc.contributor.author | Caliskan, Neva | |
dc.contributor.author | Brierley, Ian | |
dc.date.accessioned | 2021-11-18T00:30:20Z | |
dc.date.available | 2021-11-18T00:30:20Z | |
dc.date.issued | 2021-12-09 | |
dc.identifier.issn | 2041-1723 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/330720 | |
dc.description.abstract | Programmed -1 ribosomal frameshifting (PRF) in cardioviruses is activated by the 2A protein, a multi-functional virulence factor that also inhibits cap-dependent translational initiation. Here we present the X-ray crystal structure of 2A and show that it selectively binds to a pseudoknot-like conformation of the PRF stimulatory RNA element in the viral genome. Using optical tweezers, we demonstrate that 2A stabilises this RNA element, likely explaining the increase in PRF efficiency in the presence of 2A. Next, we demonstrate a strong interaction between 2A and the small ribosomal subunit and present a cryo-EM structure of 2A bound to initiated 70S ribosomes. Multiple copies of 2A bind to the 16S rRNA where they may compete for binding with initiation and elongation factors. Together, these results define the structural basis for RNA recognition by 2A, show how 2A-mediated stabilisation of an RNA pseudoknot promotes PRF, and reveal how 2A accumulation may shut down translation during virus infection. | |
dc.publisher | Springer Science and Business Media LLC | |
dc.rights | All rights reserved | |
dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
dc.title | Structural and molecular basis for Cardiovirus 2A protein as a viral gene expression switch. | |
dc.type | Article | |
prism.publicationDate | 2021 | |
prism.publicationName | Nat Commun | |
dc.identifier.doi | 10.17863/CAM.78163 | |
dcterms.dateAccepted | 2021-11-12 | |
rioxxterms.versionofrecord | 10.1038/s41467-021-27400-7 | |
rioxxterms.version | AM | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2021-11-16 | |
dc.contributor.orcid | Hill, Chris H [0000-0001-7037-0611] | |
dc.contributor.orcid | Napthine, Sawsan [0000-0001-7404-8494] | |
dc.contributor.orcid | Kibe, Anuja [0000-0001-8547-785X] | |
dc.contributor.orcid | Firth, Andrew [0000-0002-7986-9520] | |
dc.contributor.orcid | Graham, Stephen [0000-0003-4547-4034] | |
dc.contributor.orcid | Caliskan, Neva [0000-0003-0435-4757] | |
dc.contributor.orcid | Brierley, Ian [0000-0003-3965-4370] | |
dc.identifier.eissn | 2041-1723 | |
rioxxterms.type | Journal Article/Review | |
pubs.funder-project-id | Biotechnology and Biological Sciences Research Council (BB/D009499/1) | |
pubs.funder-project-id | Wellcome Trust (202797/Z/16/Z) | |
pubs.funder-project-id | Wellcome Trust (098406/Z/12/Z) | |
pubs.funder-project-id | Wellcome Trust (098406/Z/12/B) | |
pubs.funder-project-id | Wellcome Trust (106207/Z/14/Z) | |
pubs.funder-project-id | European Research Council (646891) | |
cam.issuedOnline | 2021-12-09 | |
cam.orpheus.success | 2021-11-17 - Embargo set during processing via Fast-track | |
rioxxterms.freetoread.startdate | 2021-11-16 |
Files in this item
This item appears in the following Collection(s)
-
Cambridge University Research Outputs
Research outputs of the University of Cambridge